COCM
MRNA icon

Charter Oak Capital Management’s Moderna MRNA Stock Holding History

Charter Oak Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-49
Closed -$7K – 596
2022
Q2 		$7K Sell
49
-7
-13% -$1K ﹤0.01% 649
2022
Q1 		$9K Buy
56
+10
+22% +$1.68K ﹤0.01% 647
2021
Q4 		$12K Buy
46
+8
+21% +$2.34K ﹤0.01% 594
2021
Q3 		$15K Buy
38
+1
+3% +$369 ﹤0.01% 509
2021
Q2 		$9K Sell
37
-19
-34% -$3.4K ﹤0.01% 585
2021
Q1 		$7K Sell
56
-40
-42% -$5.8K ﹤0.01% 592
2020
Q4 		$10K Buy
+96
New +$9.71K ﹤0.01% 512

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charter Oak Capital Management's MRNA Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Moderna (MRNA) in Q3 2022, closing a stake of 49 shares — an estimated $7K sold.

Charter Oak Capital Management first reported a position in MRNA in Q4 2020 and held it in 7 quarters. The position peaked at $15K in Q3 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Charter Oak Capital Management reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Charter Oak Capital Management sold 49 Moderna shares in Q3 2022, an estimated $7K.
  • Charter Oak Capital Management first reported a position in Moderna in Q4 2020 and held it in 7 quarters.
  • Charter Oak Capital Management's Moderna position peaked at $15K in Q3 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.